Trastuzumab/pertuzumab combination therapy stimulates antitumor responses through complement-dependent cytotoxicity and phagocytosis

Document Details

Document Type
Pub Defense Publication
Publication Date
Mar 22, 2022
Source ID
10.1172/jci.insight.155636

Entities

People

  • Amanda N. Summers
  • Christopher A. Rabiola
  • Erika J Crosby
  • Gangjun Lei
  • Herbert Kim Lyerly
  • Junping Wei
  • Lewis A Chodosh
  • Li-Chung Tsao
  • Tao Wang
  • Timothy N. Trotter
  • William Muller
  • Yang Xiao
  • Zachary C Hartman

Organizations

  • National Institutes of Health
  • United States Department of Defense